358 related articles for article (PubMed ID: 23257920)
21. Red ginseng extracts ameliorate high-fat diet-induced obesity and insulin resistance by activating the intestinal TGR5-mediated bile acids signaling pathway.
Li W; Zhuang T; Wang Z; Wang X; Liu L; Luo Y; Wang R; Li L; Huang W; Wang Z; Yang L; Ding L
Phytomedicine; 2023 Oct; 119():154982. PubMed ID: 37531904
[TBL] [Abstract][Full Text] [Related]
22. Glucose-lowering effects of intestinal bile acid sequestration through enhancement of splanchnic glucose utilization.
Prawitt J; Caron S; Staels B
Trends Endocrinol Metab; 2014 May; 25(5):235-44. PubMed ID: 24731596
[TBL] [Abstract][Full Text] [Related]
23. Hepatic thyroid hormone signalling modulates glucose homeostasis through the regulation of GLP-1 production via bile acid-mediated FXR antagonism.
Yan Y; Niu Z; Sun C; Li P; Shen S; Liu S; Wu Y; Yun C; Jiao T; Jia S; Li Y; Fang ZZ; Zhao L; Wang J; Xie C; Jiang C; Li Y; Feng X; Hu C; Jiang J; Ying H
Nat Commun; 2022 Oct; 13(1):6408. PubMed ID: 36302774
[TBL] [Abstract][Full Text] [Related]
24. Discovery, optimization, and evaluation of non-bile acid FXR/TGR5 dual agonists.
Miyata S; Kawashima Y; Sakai M; Matsubayashi M; Motoki K; Miyajima Y; Watanabe Y; Chikamatsu N; Taniguchi T; Tokuyama R
Sci Rep; 2021 Apr; 11(1):9196. PubMed ID: 33911126
[TBL] [Abstract][Full Text] [Related]
25. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
Burmeister MA; Ferre T; Ayala JE; King EM; Holt RM; Ayala JE
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E334-43. PubMed ID: 22094469
[TBL] [Abstract][Full Text] [Related]
26. Digestive physiology of the pig symposium: intestinal bile acid sensing is linked to key endocrine and metabolic signaling pathways.
Burrin D; Stoll B; Moore D
J Anim Sci; 2013 May; 91(5):1991-2000. PubMed ID: 23729782
[TBL] [Abstract][Full Text] [Related]
27. Effects of Manipulating Circulating Bile Acid Concentrations on Postprandial GLP-1 Secretion and Glucose Metabolism After Roux-en-Y Gastric Bypass.
Jonsson I; Bojsen-Møller KN; Kristiansen VB; Veedfald S; Wewer Albrechtsen NJ; Clausen TR; Kuhre RE; Rehfeld JF; Holst JJ; Madsbad S; Svane MS
Front Endocrinol (Lausanne); 2021; 12():681116. PubMed ID: 34084153
[TBL] [Abstract][Full Text] [Related]
28. Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR.
Jadhav K; Xu Y; Xu Y; Li Y; Xu J; Zhu Y; Adorini L; Lee YK; Kasumov T; Yin L; Zhang Y
Mol Metab; 2018 Mar; 9():131-140. PubMed ID: 29361497
[TBL] [Abstract][Full Text] [Related]
29. Intestinal Bile Acid Composition Modulates Prohormone Convertase 1/3 (PC1/3) Expression and Consequent GLP-1 Production in Male Mice.
Morimoto K; Watanabe M; Sugizaki T; Irie J; Itoh H
Endocrinology; 2016 Mar; 157(3):1071-81. PubMed ID: 26789236
[TBL] [Abstract][Full Text] [Related]
30. Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism.
Zheng X; Chen T; Jiang R; Zhao A; Wu Q; Kuang J; Sun D; Ren Z; Li M; Zhao M; Wang S; Bao Y; Li H; Hu C; Dong B; Li D; Wu J; Xia J; Wang X; Lan K; Rajani C; Xie G; Lu A; Jia W; Jiang C; Jia W
Cell Metab; 2021 Apr; 33(4):791-803.e7. PubMed ID: 33338411
[TBL] [Abstract][Full Text] [Related]
31. Potential New Approaches to Modifying Intestinal GLP-1 Secretion in Patients with Type 2 Diabetes Mellitus : Focus on Bile Acid Sequestrants.
Holst JJ; McGill MA
Clin Drug Investig; 2012 Jan; 32(1):1-14. PubMed ID: 27933595
[TBL] [Abstract][Full Text] [Related]
32. The Role of Bile Acids in Glucose Metabolism and Their Relation with Diabetes.
González-Regueiro JA; Moreno-Castañeda L; Uribe M; Chávez-Tapia NC
Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):16-21. PubMed ID: 29118282
[TBL] [Abstract][Full Text] [Related]
33. The role of FXR and TGR5 in reversing and preventing progression of Western diet-induced hepatic steatosis, inflammation, and fibrosis in mice.
Wang XX; Xie C; Libby AE; Ranjit S; Levi J; Myakala K; Bhasin K; Jones BA; Orlicky DJ; Takahashi S; Dvornikov A; Kleiner DE; Hewitt SM; Adorini L; Kopp JB; Krausz KW; Rosenberg A; McManaman JL; Robertson CE; Ir D; Frank DN; Luo Y; Gonzalez FJ; Gratton E; Levi M
J Biol Chem; 2022 Nov; 298(11):102530. PubMed ID: 36209823
[TBL] [Abstract][Full Text] [Related]
34. Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation.
Chiang JY; Pathak P; Liu H; Donepudi A; Ferrell J; Boehme S
Dig Dis; 2017; 35(3):241-245. PubMed ID: 28249273
[TBL] [Abstract][Full Text] [Related]
35. A review of bile acid sequestrants: potential mechanism(s) for glucose-lowering effects in type 2 diabetes mellitus.
Staels B
Postgrad Med; 2009 May; 121(3 Suppl 1):25-30. PubMed ID: 19494475
[TBL] [Abstract][Full Text] [Related]
36. Gluco-Metabolic Effects of Pharmacotherapy-Induced Modulation of Bile Acid Physiology.
Brønden A; Knop FK
J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31630179
[TBL] [Abstract][Full Text] [Related]
37. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1.
Katsuma S; Hirasawa A; Tsujimoto G
Biochem Biophys Res Commun; 2005 Apr; 329(1):386-90. PubMed ID: 15721318
[TBL] [Abstract][Full Text] [Related]
38.
Yue Z; Zhao F; Guo Y; Zhang Y; Chen Y; He L; Li L
Food Funct; 2024 Jun; 15(12):6450-6458. PubMed ID: 38804210
[TBL] [Abstract][Full Text] [Related]
39. Bile-induced secretion of glucagon-like peptide-1: pathophysiological implications in type 2 diabetes?
Knop FK
Am J Physiol Endocrinol Metab; 2010 Jul; 299(1):E10-3. PubMed ID: 20424139
[TBL] [Abstract][Full Text] [Related]
40. Functions of Cholesterol Metabolites.
Sato R
J Nutr Sci Vitaminol (Tokyo); 2015; 61 Suppl():S151-3. PubMed ID: 26598835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
